EGFR and cancer: In the current study, we employed multiplex fluorescent IHC staining to identify the tertiary lymphoid structures (TLSs) in early-stage EGFR-mutant lung adenocarcinoma patients, despite this cancer type being previously characterized as “immune-cold” and “immunosuppressive”.